ResearcherTottori UniversityActive in the last 2 years
Yohei Takeda
Matched on ORCID iD 0000-0003-1096-5909; OpenAlex author ID A5002266269. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- KRAS Mutations in Duodenal Lavage Fluid After Secretin Stimulation for Detection of Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006645↗
- Pancreatic Juice Cytology Evaluations Using Synthetic Secretin and Serial Pancreatic Juice Aspiration Cytological Examination for the Diagnosis of Pancreatic D… Co-author DOI 10.3390/diagnostics13091536↗
- Oligopeptide Transporter-1 is Associated with Fluorescence Intensity of 5-Aminolevulinic Acid-Based Photodynamic Diagnosis in Pancreatic Cancer Cells. Co-author DOI 10.33160/yam.2020.08.003↗
- Efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/den.13203↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taro Yamashita · 4 shared papers, 2018–2026 · strength 0.56
- Paper KRAS Mutations in Duodenal Lavage Fluid After Secretin Stimulation for Detection of Pancreatic Cancer. DOI 10.1097/sla.0000000000006645↗
- Paper Pancreatic Juice Cytology Evaluations Using Synthetic Secretin and Serial Pancreatic Juice Aspiration Cytological Exami… DOI 10.3390/diagnostics13091536↗
- Paper Oligopeptide Transporter-1 is Associated with Fluorescence Intensity of 5-Aminolevulinic Acid-Based Photodynamic Diagno… DOI 10.33160/yam.2020.08.003↗
- Hajime Isomoto · 4 shared papers, 2018–2026 · strength 0.56
- Paper KRAS Mutations in Duodenal Lavage Fluid After Secretin Stimulation for Detection of Pancreatic Cancer. DOI 10.1097/sla.0000000000006645↗
- Paper Pancreatic Juice Cytology Evaluations Using Synthetic Secretin and Serial Pancreatic Juice Aspiration Cytological Exami… DOI 10.3390/diagnostics13091536↗
- Paper Oligopeptide Transporter-1 is Associated with Fluorescence Intensity of 5-Aminolevulinic Acid-Based Photodynamic Diagno… DOI 10.33160/yam.2020.08.003↗
- Takumi Onoyama · 3 shared papers, 2018–2023 · strength 0.35
- Paper Pancreatic Juice Cytology Evaluations Using Synthetic Secretin and Serial Pancreatic Juice Aspiration Cytological Exami… DOI 10.3390/diagnostics13091536↗
- Paper Oligopeptide Transporter-1 is Associated with Fluorescence Intensity of 5-Aminolevulinic Acid-Based Photodynamic Diagno… DOI 10.33160/yam.2020.08.003↗
- Paper Efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal aden… DOI 10.1111/den.13203↗
- Kazuya Matsumoto · 2 shared papers, 2018–2023 · strength 0.24
- Paper Pancreatic Juice Cytology Evaluations Using Synthetic Secretin and Serial Pancreatic Juice Aspiration Cytological Exami… DOI 10.3390/diagnostics13091536↗
- Paper Efficacy and safety of pancreatic juice cytology by using synthetic secretin in the diagnosis of pancreatic ductal aden… DOI 10.1111/den.13203↗
- Kenji Ikezawa · 1 shared paper, 2026 · strength 0.20
- Susumu Hijioka · 1 shared paper, 2026 · strength 0.20
- Kazuo Hara · 1 shared paper, 2026 · strength 0.20
- Kazuya Matsumoto · 1 shared paper, 2026 · strength 0.20
- Reiko Ashida · 1 shared paper, 2026 · strength 0.20
- Shin Haba · 1 shared paper, 2026 · strength 0.20
- Hirokazu Kimura · 1 shared paper, 2026 · strength 0.20
- Makiko Urabe · 1 shared paper, 2026 · strength 0.20
- Keiji Hanada · 1 shared paper, 2026 · strength 0.20
- Shinichi Yachida · 1 shared paper, 2026 · strength 0.20
- Kazuyoshi Ohkawa · 1 shared paper, 2026 · strength 0.20
- Akinori Shimizu · 1 shared paper, 2026 · strength 0.20
- Masayuki Kitano · 1 shared paper, 2026 · strength 0.20
- Chigusa Morizane · 1 shared paper, 2026 · strength 0.20
- Naoyuki Yamaguchi · 1 shared paper, 2023 · strength 0.16
- Hidehito Kinoshita · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.